Second domestic sales threshold for German merger control in force today
Client Alert | 1 min read | 03.25.09
Today, 25 March 2009, an amendment to the German Act against Restraints of Competition entered into force (the day after its publication in Germany’s Official Journal). The amendment introduces a second domestic sales threshold for German merger control.
The new threshold requires that at least two parties to a transaction must each have individual sales in Germany of € 5 million (approx. US$ 6.77 million) or more. In addition, as before, the parties to the transaction must have combined worldwide sales of more than € 500 million and at least one of them must have sales in Germany of more than € 25 million.
The amendment applies to all concentrations, i.e. mergers, acquisitions and joint ventures, that have not been completed prior to its entry into force. Thus, mergers for which an agreement has already been signed but have not yet been completed need not be notified if they do not trigger the new threshold. The Bundeskartellamt will terminate all ongoing proceedings in relation to concentrations that have already been notified but do not trigger the new threshold. The Bundeskartellamt will clarify its position on its fees in these proceedings in the coming days. The fees for terminated proceedings are likely to be reduced.
Click for the official text of the amendment in German [PDF].
Insights
Client Alert | 2 min read | 11.14.25
Claim construction is a key stage of most patent litigations, where the court must decide the meaning of any disputed terms in the patent claims. Generally, claim terms are given their plain and ordinary meaning except under two circumstances: (1) when the patentee acts as its own lexicographer and sets out a definition for the term; and (2) when the patentee disavows the full scope of the term either in the specification or during prosecution. Thorner v. Sony Comput. Ent. Am. LLC, 669 F.3d 1362, 1365 (Fed. Cir. 2012). The Federal Circuit’s recent decision in Aortic Innovations LLC v. Edwards Lifesciences Corp. highlights that patentees can act as their own lexicographers through consistent, interchangeable usage of terms across the specification, effectively defining terms by implication.
Client Alert | 6 min read | 11.14.25
Microplastics Update: Regulatory and Litigation Developments in 2025
Client Alert | 6 min read | 11.13.25
